NasdaqGS - Nasdaq Real Time Price USD
ImmunityBio, Inc. (IBRX)
2.8150
-0.0250
(-0.88%)
As of 3:55:44 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -0.1 | -0.11 | -0.5 | -0.27 |
| Low Estimate | -0.12 | -0.13 | -0.55 | -0.28 |
| High Estimate | -0.09 | -0.09 | -0.44 | -0.26 |
| Year Ago EPS | -- | -0.12 | -0.59 | -0.5 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 3 | 3 |
| Avg. Estimate | 23.1M | 30.7M | 104.63M | 245.23M |
| Low Estimate | 21.7M | 26M | 91.4M | 218.9M |
| High Estimate | 24.5M | 35.39M | 124M | 273.6M |
| Year Ago Sales | 1.05M | 6.11M | 14.74M | 104.63M |
| Sales Growth (year/est) | 2,106.30% | 402.70% | 609.62% | 134.37% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.15 | -0.18 | -0.13 | -0.14 |
| EPS Actual | -0.2 | -0.12 | -0.08 | -0.15 |
| Difference | -0.05 | 0.06 | 0.05 | -0.01 |
| Surprise % | -33.33% | 33.33% | 38.46% | -7.14% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.1 | -0.11 | -0.5 | -0.27 |
| 7 Days Ago | -0.14 | -0.13 | -0.53 | -0.34 |
| 30 Days Ago | -0.13 | -0.12 | -0.51 | -0.34 |
| 60 Days Ago | -0.13 | -0.12 | -0.51 | -0.34 |
| 90 Days Ago | 0 | 0 | -0.42 | -0.15 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | -- |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IBRX | -- | 8.33% | 16.10% | 45.45% |
| S&P 500 | 13.32% | 2.67% | 7.78% | 13.75% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/12/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 5/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/28/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 4/28/2025 |
| Maintains | D. Boral Capital: Buy to Buy | 4/23/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/16/2025 |
Related Tickers
IOVA Iovance Biotherapeutics, Inc.
1.8250
+9.92%
CTMX CytomX Therapeutics, Inc.
2.1497
+5.90%
SMMT Summit Therapeutics Inc.
23.92
+0.21%
BLUE bluebird bio, Inc.
4.9750
+0.10%
SGMO Sangamo Therapeutics, Inc.
0.4963
+5.58%
ARDX Ardelyx, Inc.
4.0450
+4.25%
VKTX Viking Therapeutics, Inc.
27.53
-3.17%
TGTX TG Therapeutics, Inc.
34.88
+1.51%
ALT Altimmune, Inc.
5.49
-1.70%
CADL Candel Therapeutics, Inc.
5.69
+6.36%